(Q28323816)

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

26 February 2023

1 reference

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

26 February 2023

author name string

A. D. Mosijczuk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A291472

26 February 2023

F. B. Ruymann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A291472

26 February 2023

A. D. Mease

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A291472

26 February 2023

R. D. Bernier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A291472

full work available at URL

26 February 2023

language of work or name

English

0 references

publication date

November 1979

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

26 February 2023

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

26 February 2023

0 references

44

0 references

issue

5

0 references

page(s)

1582-7

0 references

cites work

Adriamycin. A new anticancer drug with significant clinical activity

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197911%2944%3A5%3C1582%3A%3AAID-CNCR2820440507%3E3.0.CO%3B2-H

Doxorubicin Cardiomyopathy: Evaluation by Phonocardiography, Endomyocardial Biopsy, and Cardiac Catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197911%2944%3A5%3C1582%3A%3AAID-CNCR2820440507%3E3.0.CO%3B2-H

Adriamycin and Radiation: Synergistic Cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197911%2944%3A5%3C1582%3A%3AAID-CNCR2820440507%3E3.0.CO%3B2-H

Cardiac toxicity of daunorubicin

21 January 2018

3

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

26 February 2023

Cancer Treatment Reports

4

62

873

Bristow

1978

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

26 February 2023

Adriamycin—A Review

6

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia

26 February 2023

9

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin

26 February 2023

10

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

A clinicopathologic analysis of adriamycin cardiotoxicity

26 February 2023

11

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

Journal of Pharmacology and Experimental Therapeutics

26 February 2023

15

178

216

Mhatre

1971

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

26 February 2023

17

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

Adriamycin cardiotoxicity in children.Case reports, literature review, and risk factors

26 February 2023

18

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

Adriamycin cardiotoxicity in man

26 February 2023

19

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

Combination 6-mercaptopurine-adriamycin in refractory adult acute leukemia

26 February 2023

20

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

26 February 2023

Cancer Treatment Reports

22

61

1736

Smith

1977

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases

26 February 2023

23

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease

26 February 2023

25

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

26 February 2023

26

33

921

Weil

1973

1 reference

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(197911)44:5%3C1582::AID-CNCR2820440507%3E3.0.CO;2-H

26 February 2023

Identifiers

10.1002/1097-0142(197911)44:5<1582::AID-CNCR2820440507>3.0.CO;2-H

0 references

Fatcat ID

release_sqo7wolnezchjpkhx63f7ina2e

0 references